Skip to content
Explore the Longevity Puptides food-bowl spray collection. View formula details and availability updates →

Ingredient science

Epitalon for Dogs

Epitalon is a synthetic four-amino-acid peptide investigated in cell and aging research. Human-cell telomerase experiments and rodent studies are not evidence of longer life in dogs. Epitalon and the tissue-derived preparation epithalamin are also distinct substances.

What is Epitalon?

Epitalon is the AEDG tetrapeptide. It is often discussed alongside Epithalamin, but they are not the same material: Epithalamin refers to a pineal-gland polypeptide extract, while Epitalon is the defined synthetic tetrapeptide developed from work on pineal preparations. The literature describes several proposed actions, including effects on melatonin-related signaling, immune-cell activity, antioxidant pathways, and telomerase-related biology, but the mechanism is not settled. In a 2025 study, Epitalon increased telomere length in cultured human normal epithelial and fibroblast cells alongside increased hTERT expression and telomerase activity; cancer cell lines also showed telomere extension involving alternative lengthening of telomeres. That result is cellular evidence, not evidence that Epitalon lengthens telomeres or improves outcomes in dogs. The main long-term mouse study likewise does not support a simple claim of broad lifespan extension: mean lifespan was unchanged, although the last 10% of survivors and maximum lifespan were higher, and leukemia incidence was lower while total spontaneous tumor incidence was unchanged.

How strong is the evidence?

The verified literature supports describing Epitalon as an experimental research compound with cell and animal findings, not as a proven canine longevity intervention. Epitalon should be kept distinct from Epithalamin, the pineal extract from which its development was derived. The human-cell telomere study cannot be presented as evidence in dogs, and the mouse lifespan study cannot be summarized as a 25% lifespan extension or a 30–50% reduction in tumors: it found no change in mean lifespan or total spontaneous tumor incidence. No direct canine lifespan study was identified in the verified sources. Evidence is insufficient to make safety, disease-prevention, cure, or outcome guarantees, and this guide intentionally provides no dosing instructions.

The best way to judge a paper is to start with what was tested: the molecule, animal or cell model, administration route, comparator and measured endpoint. A laboratory change is different from a dog becoming more comfortable, and a small uncontrolled case series cannot separate the effect of several ingredients from other care.

The studies, with species and route.

Review

Overview of Epitalon—Highly Bioactive Pineal Tetrapeptide with Promising Properties

This 2025 review synthesizes in vitro, in vivo, and limited clinical literature on Epitalon. It describes reported effects on melatonin synthesis, interleukin-2 expression, murine thymocyte activity, antioxidant and neuroprotective pathways, and telomerase-related activity, while emphasizing that the compound's mechanism remains unclear and that structural and pharmacodynamic evidence is incomplete.

Review of Epitalon/AEDG research; includes discussion of Epithalamin-derived history and findings from cell, animal, and human studies, but does not provide canine efficacy evidence.

Araj SK, Brzezik J, Mądra-Gackowska K, Szeleszczuk Ł. Overview of Epitalon—Highly Bioactive Pineal Tetrapeptide with Promising Properties. International Journal of Molecular Sciences. 2025;26(6):2691. doi:10.3390/ijms26062691.

Read the source

Primary animal study

Effect of Epitalon on Biomarkers of Aging, Life Span and Spontaneous Tumor Incidence in Female Swiss-derived SHR Mice

In 54 treated and 54 control female mice, monthly Epitalon injections did not change mean lifespan, body weight, food consumption, or total spontaneous tumor incidence. The study reported a 13.3% increase in lifespan among the last 10% of survivors, a 12.3% increase in maximum lifespan, and a lower leukemia incidence. These results are mouse findings and do not establish a dog lifespan effect or general anticancer effect.

Female outbred Swiss-derived SHR mice followed from three months of age to natural death; long-term subcutaneous administration under the study protocol.

Anisimov VN, Khavinson VK, Popovich IG, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4:193-202. doi:10.1023/A:1025114230714.

Read the source

Primary in vitro study

Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity

Epitalon produced dose-dependent telomere-length increases in cultured human normal epithelial and fibroblast cells alongside increased hTERT expression and telomerase activity. Breast cancer cell lines also showed telomere extension, with alternative lengthening of telomeres contributing in those cells. The findings concern cultured human cells and do not demonstrate a clinical aging benefit, a canine effect, or a safety outcome.

Laboratory study using human normal epithelial and fibroblast cells plus breast cancer cell lines; molecular and telomere endpoints rather than animal or clinical outcomes.

Al-dulaimi S, Thomas R, Matta S, Roberts T. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. 2025;26(5):178. doi:10.1007/s10522-025-10315-x.

Read the source

What does the route of administration change?

An injection, laboratory cell exposure and oral formulation can produce very different exposure. Swallowed peptides encounter stomach conditions, digestive enzymes, mucus and the intestinal barrier. Enteric carrier design addresses a delivery step; it does not convert an injected study into a food-bowl spray trial.

Understand pH-responsive delivery

How should a dog owner use this information?

Use the original papers to understand why scientists investigate this ingredient, not to create a dosing schedule. For a dog with symptoms or taking medication, discuss the actual formulation and full ingredient list with your veterinarian. New or persistent changes in movement, appetite, sleep or behavior deserve a veterinary assessment rather than an ingredient experiment.

Education, not a collection ingredient.

Epitalon is not an ingredient in the ten Longevity Puptides sprays. This guide addresses a dog-owner research question; it does not introduce an Epitalon product.

Explore the approved collection →

Keep exploring.

Published by Longevity Puptides

Published: November 2, 2026 · Substantive update: November 2, 2026

Ingredient studies with evidence grades, species and administration routes.

Editorial standards and corrections